IDENTIFYING THERAPEUTIC VULNERABILITIES IN NRF2 DEPENDENT CANCERS

被引：0
|
作者：
Levonen, Anna-Liisa [1 ]
机构：
[1] Univ Eastern Finland, Kuopio, Finland
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2022年 / 189卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [11] Advances and challenges in therapeutic targeting of NRF2
    Dinkova-Kostova, Albena T.
    Copple, Ian M.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (03) : 137 - 149
  • [12] Crosstalk between Nrf2 and the proteasome: Therapeutic potential of Nrf2 inducers in vascular disease and aging
    Chapple, Sarah J.
    Siow, Richard C. M.
    Mann, Giovanni E.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2012, 44 (08): : 1315 - 1320
  • [13] TARGETING Nrf2 ANTIOXIDATIVE PATHWAY AS A NOVEL THERAPEUTIC STRATEGY FOR IDH1-MUTATED CANCERS
    Liu, Yang
    Lu, Yanxin
    Celiku, Orieta
    Li, Aiguo
    Yang, Chunzhang
    NEURO-ONCOLOGY, 2018, 20 : 278 - 278
  • [14] TARGETING Nrf2 ANTIOXIDATIVE PATHWAY AS A NOVEL THERAPEUTIC STRATEGY FOR IDH1-MUTATED CANCERS
    Liu, Yang
    Lu, Yanxin
    Celiku, Orieta
    Li, Aiguo
    Yang, Chunzhang
    NEURO-ONCOLOGY, 2018, 20 : 102 - 102
  • [15] The interplay between microRNAs and Nrf2 signaling in human cancers
    Panahizadeh, Reza
    Vatankhah, Mohammad Amin
    Safari, Ali
    Danesh, Hesam
    Nazmi, Negin
    Gholizadeh, Pourya
    Soozangar, Narges
    Jeddi, Farhad
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [16] Genetic, metabolic and immunological features of cancers with NRF2 addiction
    Kitamura, Hiroshi
    Takeda, Haruna
    Motohashi, Hozumi
    FEBS LETTERS, 2022, 596 (16) : 1981 - 1993
  • [17] The Role of Nrf2 in Glioma: Therapeutic Targeting Strategies
    Harifi-Mood, Mohammad Sadra
    Alemzadeh, Effat
    Barati, Danyal
    Dehghani, Amir Hossein
    Siroosi, Fatemeh Zahra
    Aschner, Michael
    Samini, Fariborz
    Samarghandian, Saeed
    Farkhondeh, Tahereh
    CURRENT CANCER DRUG TARGETS, 2025,
  • [18] Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases
    Nakagami, Yasuhiro
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
  • [19] Brusatol, an NRF2 inhibitor for future cancer therapeutic
    Cai, Sabrina J.
    Liu, Yang
    Han, Sue
    Yang, Chunzhang
    CELL AND BIOSCIENCE, 2019, 9 (1):
  • [20] Role of NRF2 as a Therapeutic Target for RGC Protection
    Li, Qiutang
    Liu, Ting
    Rong, Yu
    Zhang, Xin
    Luk, Alvin
    Li, Bin
    MOLECULAR THERAPY, 2022, 30 (04) : 143 - 143
12345